Inhibition of endothelial cell thromboresistance by homocysteine

Journal of Nutrition

Volumn 130, Issue 2 SUPPL., 2000, Pages

  Ling, Qi ^a   Hajjar, Katherine A ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Endothelial cell; Homocysteine elongation factors; Plasmin; Tissue plasminogen activator

Indexed keywords

ELONGATION FACTOR 1; HOMOCYSTEINE; LIPOCORTIN 2; PLASMIN; PROCOAGULANT; THIOL DERIVATIVE; TISSUE PLASMINOGEN ACTIVATOR;

AMINO ACID METABOLISM; ANTICOAGULATION; CELL FUNCTION; CONFERENCE PAPER; ENDOTHELIUM CELL; FIBRINOLYSIS; HUMAN; THROMBOCYTE; THROMBOGENESIS; VASCULAR DISEASE; VASODILATATION;

EID: 0033985101     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/130.2.373s     Document Type: Conference Paper

References (31)

1. Cesarman, G. M., Guevara, C. A. & Hajjar, K. A. (1994) An endothelial cell receptor for plasminogen/tissue plasminogen activator: II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation. J. Biol. Chem. 269: 21198-21203.
2. Chacko, G., Ling, Q. & Hajjar, K. A. (1998) Induction of acute translational response genes by homocysteine: elongation factors EF-1 alpha, beta, and delta. J. Biol. Chem. 273: 19840-19846.
3. Di Minno, G., Davi, G., Margaglione, M., Cirillo, F., Grandone, E., Ciabattoni, G., Catalano, I., Strisciuglio, P., Andria, G., Patrono, C. & Mancini, M. (1993) Abnormally high thromboxane biosynthesis in homozygous homocystinuria: evidence for platelet involvement and probucol-sensitive mechanism. J. Clin. Investig. 92: 1400-1406.
4. Fryer, R. H., Wilson, B. D., Gubler, D. B., Fitzgerald, L. A. & Rodgers, G. M. (1993) Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells. Arterioscler. Thromb. 13: 1327-1333.
5. Gonen, H., Smith, C. E., Siegel, N. R., Kahana, C., Merrick, W. C., Chakraburtty, K., Schwartz, A. L. & Ciechanover, A. (1994) Protein synthesis elongation factor EF-1 alpha is essential for ubiquitin-dependent degradation of certain N-acetylated proteins and may be substituted for by the bacterial elongation factor EF-Tu. Proc. Natl. Acad. Sci. U.S.A. 91: 7648-7652.
6. Hajjar, K. A. (1991) The endothelial cell tissue plasminogen activator receptor: specific interaction with plasminogen. J. Biol. Chem. 266: 21962-21970.
7. Hajjar, K. A. (1993) Homocysteine-induced modulation of tissue plasminogen activator to its endothelial cell membrane receptor. J. Clin. Investig. 91: 2873-2879.
8. Hajjar, K. A. (1998) The molecular basis of fibrinolysis. In: Hematology of Infancy and Childhood (Nathan, D. G. & Orkin, S. H., eds.), pp. 1557-1573. W. B. Saunders, Philadelphia, PA.
9. Hajjar, K. A., Guevara, C. A., Lev, E., Dowling, K. & Chacko, J. (1996) Interaction of the fibrinolytic receptor, annexin II, with the endothelial cell surface: essential role of endonexin repeat 2. J. Biol. Chem. 271: 21652-21659.
10. Hajjar, K. A. & Hamel, N. M. (1990) Identification and characterization of human endothelial cell membrane binding sites for tissue plasminogen activator and urokinase. J. Biol. Chem. 265: 2908-2916.
11. Hajjar, K. A. & Jacovina, A. T. (1998) Modulation of annexin II by homocysteine: implications for atherothrombosis. J. Investig. Med. 46: 1-6.
12. Hajjar, K. A., Jacovina, A. T. & Chacko, J. (1994) An endothelial cell receptor for plasminogen and tissue plasminogen activator: I. Identity with annexin II. J. Biol. Chem. 269: 21191-21197.
13. Hajjar, K. A., Mauri, L., Jacovina, A. T., Zhong, F., Mirza, U. A., Padovan, J. C. & Chait, B. T. (1998) Tissue plasminogen activator binding to the annexin II tail domain: direct modulation by homocysteine. J. Biol. Chem. 273: 9987-9993.
14. Hayashi, T., Honda, G. & Suzuki, K. (1992) An atherogenic stimulus homocysteine inhibits cofactor activity of thrombomodulin and enhances thrombomodulin expression in human umbilical vein endothelial cells. Blood 79: 2930-2936.
15. Kassam, G., Choi, K. S., Ghuman, J., Kang, H. M., Fitzpatrick, S. L., Zackson, T., Zackson, S., Toba, M., Shinomiya, A. & Waisman, D. M. (1998) The role of annexin II tetramer in the activation of plasminogen. J. Biol. Chem. 273: 4790-4799.
16. Kokame, K., Kato, H. & Miyata, T. (1996) Homocysteine-respondent genes in vascular endothelial cells identified by differential display analysis. J. Biol. Chem. 271:29659-29665.
17. Lentz, S. R. & Sadler, J. E. (1991) Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine. J. Clin. Investig. 88: 1906-1914.
18. Lentz, S. R., Sobey, C. G., Piegers, D. J., Bhopatkar, M. Y., Faraci, F. M., Malinow, M. R. & Heistad, D. D. (1996) Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia. J. Clin. Investig. 98: 24-29.
19. Merrick, W. C. (1992) Mechanism and regulation of eukaryotic protein synthesis. Microbiol. Rev. 56: 291-315.
20. Morris, D. R. (1995) Growth control of translation in mammalian cells. Prog. Nucleic Acid Res. 51: 339-363.
21. Nishinaga, M., Ozawa, T. & Shimada, K. (1993) Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells. J. Clin. Investig. 92: 1381-1386.
22. Proud, C. G. (1994) Peptide-chain elongation in eukaryotes. Mol. Biol. Rev. 19: 161-170.
23. Raynal, P. & Pollard, H. B. (1994) Annexins: the problem of assessing the biologic role for a gene family of multifunctional calcium- and phospholipid-binding proteins. Biochim. Biophys. Acta 1197: 63-93.
24. Rodgers, G. M. & Conn, M. T. (1990) Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells. Blood 75: 895-901.
25. Rodgers, G. M. & Kane, W. H. (1986) Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator. J. Clin. Investig. 77: 1909-1916.
26. Spano, F., Raugei, G., Palla, E., Colella, C. & Melli, M. (1990) Characterization of the human lipocortin-2-encoding multigene family: its structure suggests the existence of a short amino acid unit undergoing duplication. Gene 95: 243-251.
27. Stamler, J. S., Osborne, J. A., Jaraki, O., Rabbani, L. E., Mullins, M., Singel, D. & Loscalzo, J. (1993) Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J. Clin. Investig. 91: 308-318.
28. Swairjo, M. A. & Seaton, B. A. (1994) Annexin structure and membrane interactions: a molecular perspective. Annu. Rev. Biophys. Biomol. Struct. 23: 193-213.
29. Tsai, J. C., Perrella, M. A., Yoshizumi, M., Hsieh, C., Haber, E., Schlegel, R. & Lee, M. (1994) Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc. Natl. Acad. Sci. U.S.A. 91: 6369-6373.
30. Tsai, J. C., Wang, H., Perrella, M. A., Yoshizumi, M., Sibinga, N.E.S., Tan, L. C., Haber, E., Chang, T.H.T., Schlegel, R. & Lee, M. (1996) Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells. J. Clin. Investig. 97: 146-153.
31. Wang, J., Dudman, N.P.B. & Wilcken, D. E. (1993) Effects of homocysteine and related compounds on prostacyclin production by cultured vascular endothelial cells. Thromb. Haemost. 6: 1047-1052.